653 related articles for article (PubMed ID: 16875474)
1. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma.
Lee DA; Ratner D
Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474
[TBL] [Abstract][Full Text] [Related]
2. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery.
Huang CC; Boyce S; Northington M; Desmond R; Soong SJ
J Am Acad Dermatol; 2004 Oct; 51(4):585-91. PubMed ID: 15389195
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
4. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
6. Is curettage really necessary for basal cell carcinoma before Mohs micrographic surgery?
Kimyai-Asadi A; Jih MH; Goldberg LH
Dermatol Surg; 2004 May; 30(5):820; author reply 821-2. PubMed ID: 15099334
[No Abstract] [Full Text] [Related]
7. A direct comparison of visual inspection, curettage, and epiluminescence microscopy in determining tumor extent before the initial margins are determined for Mohs micrographic surgery.
Guardiano RA; Grande DJ
Dermatol Surg; 2010 Aug; 36(8):1240-4. PubMed ID: 20666811
[TBL] [Abstract][Full Text] [Related]
8. [Mohs micrographic surgery: our first 100 patients].
Alonso T; Sánchez P; González A; Ingelmo J; Ruiz I; Delgado S; Rodríguez MA
Actas Dermosifiliogr; 2008 May; 99(4):275-80. PubMed ID: 18394403
[TBL] [Abstract][Full Text] [Related]
9. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face.
Otley CC
Arch Dermatol; 2006 Sep; 142(9):1235; author reply 1235-6. PubMed ID: 16983019
[No Abstract] [Full Text] [Related]
12. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
Alcalay J; Alkalay R; Hazaz B
Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
[TBL] [Abstract][Full Text] [Related]
14. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
Aoyagi S; Nouri K
Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
[TBL] [Abstract][Full Text] [Related]
15. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery.
Kaplan AL; Weitzul SB; Taylor RS
Dermatol Surg; 2008 Jan; 34(1):15-9. PubMed ID: 18053056
[TBL] [Abstract][Full Text] [Related]
17. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
18. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
19. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
20. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
